Press Program 2021
The AACR Annual Meeting 2021 press program included a virtual press conference featuring five newsworthy studies from the Annual Meeting. The AACR also issued news releases on 10 additional abstracts.
Press Conference
The AACR hosted a virtual press conference featuring presentations of newsworthy research from the AACR Annual Meeting 2021 on Friday, April 9.
AACR President Antoni Ribas, MD, PhD, FAACR, and Annual Meeting Program Chair Charles Swanton, MBPhD, FRCP, FMedSci, FRS, FAACR, moderated the press conference.
View the Press Conference
The following studies were presented:
- This study was simultaneously published in The Lancet Oncology.
- Presented by: Matthew J. Matasar, MD, Memorial Sloan Kettering Cancer Center (MSK)
- Presented by: Jessica Hassel, MD, University Hospital Heidelberg in Germany
- Presented by: Patrick Forde, MBBCh, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University
- Presented by: Emily Blauel, MD, Children’s Hospital of Philadelphia
Healthy Lifestyle May Offset Risk of Lethal Prostate Cancer in Men With High Genetic Risk
- Presented by: Anna Plym, PhD, Brigham and Women’s Hospital and Harvard T. H. Chan School of Public Health
ADDITIONAL NEWS RELEASES
Cancer Aneuploidy May Predict Responses to Immunotherapy in Patients with Non-small Cell Lung Cancer
- Presented by: João Alessi, MD, Dana-Farber Cancer Institute
Oncolytic Herpesvirus Shows Early Promise in Pediatric Patients with High-grade Glioma
- This study was simultaneously published in the New England Journal of Medicine.
- Presented by: Gregory Friedman, MD, Alabama Center for Childhood Cancer and Blood Disorders, University of Alabama at Birmingham and Children’s of Alabama
Bispecific CAR T-cell Therapy Shows Early Promise for Relapsed or Refractory B-cell Lymphoma
- Presented by: Sanaz Ghafouri, MD, University of California Los Angeles Medical Center
- Presented by: Robert Hawkins, MD, PhD, Instil Bio Inc.
- Presented by: Andreana N. Holowatyj, PhD, MS, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center
Ovarian Cancer Patients Face Increased Risk of Mental Illness
- Presented by: Siqi Hu, a PhD candidate, University of Utah and Huntsman Cancer Institute
CREB1 Identified as Potential Therapeutic Target for the Treatment of Pancreatic Cancer
- This study was simultaneously published in the AACR journal Cancer Discovery.
- Presented by: Michael Kim, MD, The University of Texas MD Anderson Cancer Center
- Presented by: Thomas Marron, MD, PhD, The Tisch Cancer Institute
- Presented by: Francesco Ravera, MD, PhD, University of Genoa, Italy
- Presented by: Neelam Sinha, MS, Center for Cancer Research, National Cancer Institute